Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.002 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |